crolibulin TM

Related by string. * : / TMD . Tm . TMs . TMS . tm : FinancialWire tm website . Forrester Wave TM . TM EA SPORTS . Contact FinancialWire tm . Ibis T# TM Biosensor . Xerox Phaser TM . Addressing Psoriasis TM . Nintendo GameCube TM . Citrix Synergy TM . ICO mim TM . Impart IQ TM . through eReleases TM . Onko Sure TM . AMD Opteron TM . Solaris TM . Augment TM . FinancialWire tm . deCODE Glaucoma TM * *

Related by context. Frequent words. (Click for all words.) 63 Ceplene R 60 Ceplene ® 57 SILENOR TM 57 TOCOSOL Paclitaxel 57 orBec R 56 valopicitabine 55 Fodosine TM 54 vernakalant iv 54 BYDUREON 53 confirmatory Phase III 53 vernakalant oral 53 Phase IIa clinical trials 52 Zerenex 52 Phenoptin 52 OFIRMEV 52 Disclaimer Past performance 52 ADVENTRX 51 pralatrexate 51 ambrisentan 50 FavId 50 HEPLISAV 50 alvimopan 50 ONSOLIS 50 PREOS 50 talactoferrin 50 StaphVAX 50 requisite regulatory approvals 49 regulatory authorizations 49 materially adversely affected 48 MOZOBIL 48 post insulting discriminatory 48 Phase III trials 48 commercialization milestones 48 Genaera 48 Orphan Drug designation 48 Fast Track Designation 47 stockholder approvals 47 Exalgo 47 risks anduncertainties 47 BENLYSTA 47 alogliptin 46 voclosporin 46 KRYSTEXXA 46 autoimmune indications 46 clinical trials 46 Orphan Drug status 46 ATryn R 46 methylnaltrexone 46 sBLA 46 Xyotax 46 regulatory approval 45 Approvable Letter 45 NovaDel 45 CORTOSS 45 successfully commercialized 45 Biologics License Application 45 your posting privledges 45 Surfaxin 45 Marketing Authorization Application 45 Fast Track designation 45 5 NorthEscambia.com reserves 45 velaglucerase alfa 44 successfully commercialize 44 Opana ER 44 Promacta 44 Phase III clinical trials 44 EPIX Pharmaceuticals 44 threatening defamatory obscene 44 Bronchitol 43 Gestiva 43 Regulatory Approval 43 Renvela 43 DAVANAT ® 43 necessary regulatory approvals 43 Orphan Drug Designation 43 orphan designation 43 Neuromed 43 Mozobil 43 recompetes 43 IND enabling 43 NDA submission 43 Esbriet 43 VioQuest 43 regulatory approvals 43 PDUFA date 43 taliglucerase alfa 42 Eligard 42 negatives thereof 42 Reloxin 42 DRAXIS 42 Complete Response letter 42 InKine 42 Rhucin ® 42 Cellegy 42 JZP 6 42 Priority Review 41 FDA Approval 41 MacroChem 41 orphan drug 41 Hiru Corporation 41 Marketing Authorization Application MAA

Back to home page